"Innovative Scoring System in Breast Cancer Post Neoadiuvant Chemotherapy"

CompletedOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

December 31, 2021

Conditions
Early Breast Cancer
Interventions
DIAGNOSTIC_TEST

Evaluation with new scoring system

"Evaluate whether patients who have received surgery in line with the developed scoring system have a better aesthetic and oncological outcomes"

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05213403 - "Innovative Scoring System in Breast Cancer Post Neoadiuvant Chemotherapy" | Biotech Hunter | Biotech Hunter